SUMMARY Two groups of patients with primary Parkinsonism were studied with the ganzfeld electroretinogram (ERG): (1) seven patients who had never received dopamimetic agents, and (2) six patients given an infusion of levodopa following a period of medication withdrawal. Patients in the first category had a subtle increase in the latency of their short-wavelength sensitive cone response recorded from the retina ipsilateral to their more symptomatic side. Most patients in the second category demonstrate an improvement in their ERG when the responses recorded following levodopa infusion were compared with baseline responses obtained during the period of medication withdrawal. These results suggest that one role of retinal dopamine may be maintenance of normal retinal responsiveness to flash stimuli.
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Destruction of the nigrostriatal dopaminergic system is known to occur in patients with Parkinson's disease.' A more generalised defect in dopaminergic neurotransmission in Parkinson's disease has been suggested. 2 One possible clinical manifestation of a more global involvement is the prolonged latency of the visual evoked potential (VEP), the extent of which has been correlated with the clinical severity of the disease.3 Two related findings suggest that the delayed VEP may be related to dopaminergic pathways in the retina. The first finding is the interocular differences in VEP latency. 4 The second is that dopamine depleters and blockers increase latency of the VEP recorded over the visual cortex without altering the conduction time within the optic tract. (blue) was interposed between the Grass flash tube and light port into the ganzfeld. 4 The dark-adapted red-green cone potentials were isolated using a Wratten 21 filter (red).
To isolate the blue-cone response, a blue flash, generated using the same 47B filter, was super-imposed on a 6-1 fL yellow background created with a Wratten 26 filter.'5 Using this stimulus configuration, the longer-wavelength sensitive cones and rods were light adapted while the blue-sensitive cones remained dark adapted. Light adaptation with this 
yellow background was continued for a minimum of 2 minutes before the blue flashes were started.
ERG oscillatory potentials (OPs) were elicited under conditions of both dark-and light-adaptation; only the highest intensity flash was used. Under conditions of darkadaptation both red and white flashes were used; under conditions of light-adaptation only white flashes were used. To record the OPs, the analogue ERG signal was filtered between 70 and 250 Hz; the interstimulus delay was 30 seconds in accordance with the procedure of Algevere and Westbeck.'6 For all waveforms except for the OPs, four responses were averaged in cooperative patients. For the OPs, the response to the first flash was discarded and the next two responses were averaged when averaging was possible. Under the conditions described, the OPs show virtually no variability between responses.
Light-adapted cone responses were obtained using white flashes superimposed on a white background (11*5 fL). Subjects were exposed to this background light for a minimum of I minute before the white flashes were begun.
Statistical analysis An analysis of variance for repeated measures and two "within" factors was used to evaluate both the effects of lateralised disease and to examine the effects of the levodopa infusion. The two factors for the first study were the disease laterality and the stimulus intensity. In the second study, the two factors were the drug effect and the stimulus intensity. The data were analysed using the General Linear Model of the SAS software package (ed. 4, SAS Institute; Cary, N.C.).
Results

Untreated patients
The latency of the blue cone response was prolonged when the ERG obtained ipsilateral to the impaired side was compared to that recorded from the contralateral eye. The latency of the ipsilateral ERG was prolonged by a mean of 3% across all intensities; this trend was more manifest at higher intensities. This asymmetry, although significant at the p < 0-01 level, loses statistical significance when the Bonferoni correction (BFC) is made. The mean + 1 S.D. for each intensity is provided in table 3.
Patients treated with levodopa infusion
Under conditions of dark-adaptation, the rod b-wave increased in amplitude by a mean of 12% across all intensities following infusion of levodopa, (p < 0-002 IA) . Under conditions of light-adaptation, the a-wave amplitude increased by a mean of 12% in amplitude (p < 0-02 following the BFC) and the b-wave increased by a mean of 24% in amplitude, (p < 0-002 following the BFC) (fig 1 B and  C) . Although there is a significant trend for levodopa to enhance the amplitude of several parameters of the ERG, inspection of figure 1 shows that at some intensities no effect of levodopa could be demonstrated. Amplitude enhancement under conditions of light adaptation occurred in association with a mean 2% decrease in the latency of the light-adapted b-wave (p < 0002 following the BFC); both amplitude enhancement and a faster latency to peak reflect a relative improvement in the ERG.
In the light of general ERG improvement, it is interesting that two patients displayed divergent patterns of drug response. Patient I was treated initially with 0 5mg/ml/min infusion. This resulted in a general increase of amplitude and decrease of latency with respect to baseline values (fig 2) . Prior to record- BIDA refers to the blue flash under dark-adapted conditions which will elicit the rod response; b(r) depicts the peak of the rod b-wave. RIDA refers to the redflash under dark-adapted conditions; this stimulus elicits the R-G cone response. The peak of the cone a-wave is denoted by "a" and the peak of the cone b-wave is denoted by b(c 17 and is consistent with the recent evidence ofdopamine receptors on the outer segments of photoreceptors. '8 19 The general findings of the levodopa infusion study are consistent with the ERG recovery pattern seen in patient 1 (fig 3) . This pattern of recovery resembles that observed in rabbits20 and in cats2' in which reserpine attenuated the ERG and subsequent administration of levodopa (but not of norepinephrine) resulted in a return of the waveform toward normal. Corroborative results have been obtained in rats administered with dopaminergic blockers followed by dopaminergic agonists. 5 In a clinically-related study, Parkinsonian patients received a VER before and after treatment with levodopa. 22 The latency decreased in nine out of 14 patients, changed only slightly in four and increased in one patient. In two patients, latency shortened in one eye and became longer in the other. Thus, while most subjects showed enhanced VER responses, three of 14 patients provided evidence for a decrement in visual responsiveness following levodopa administration. These data approximate our findings in which one of 6 patients showed a generalised ERG decrement (Patient 6; table 2); these data may be consistent with the neurotoxic effect of levodopa demonstrated by others.9 10 Our collective data suggest that the retina is at least one element in the visual system where modulation of dopamine may regulate the responsiveness to light flashes.
